For example, in cases where gliomas exhibit ambiguous imaging features, ML models can flag tumors with radiomic signatures highly indicative of IDH1 mutation, prompting radiologists to consider additional molecular testing or closer follow-up. The gene discussed is IDH1; the disease is central nervous system cancer.